Insider trading

Period: 120 months Stock: RGNX Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

26 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

26 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

26 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

26 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
26 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
26 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

26 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Jul 2026
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$29.48K 2,161 at 13.64
1.0%
Planned (10b5-1)
11 May 2026
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$168.71K 15,309 at 11.02
6.2%
Planned (10b5-1)
10 Mar 2026
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$53.03K 5,124 at 10.35
2.0%
Planned (10b5-1)
9 Oct 2025
Simpson Curran Chief Executive Officer
Sold on a plan
$262.63K 20,811 at 12.62
8.8%
Planned (10b5-1)
29 Sep 2025
Simpson Curran Chief Executive Officer
Sold on a plan
$76.47K 7,624 at 10.03
3.1%
Planned (10b5-1)
10 Sep 2025
Simpson Curran Chief Executive Officer
Sold on a plan
$77.49K 7,734 at 10.02
3.1%
Planned (10b5-1)
12 May 2025
Mills Kenneth T. Director
Sold on a plan
$163.05K 20,602 at 7.91
4.2%
Planned (10b5-1)
1 Oct 2024
Sold on a plan
$101.05K 10,000 at 10.11
47.0%
Planned (10b5-1)
3 Sep 2024
Sold on a plan 2×
$115.59K 10,000 at 11.56
47.0%
Planned (10b5-1)
1 Aug 2024
Sold on a plan 3×
$136.45K 10,100 at 13.51
47.2%
Planned (10b5-1)
1 Aug 2024
Simpson Curran Chief Executive Officer
Sold on a plan
$1.50K 100 at 15.00
0.1%
Planned (10b5-1)
29 Jul 2024
Sold on a plan
$165.50K 11,000 at 15.05
49.4%
Planned (10b5-1)
29 Jul 2024
Simpson Curran Chief Executive Officer
Sold on a plan
$145.11K 9,648 at 15.04
5.4%
Planned (10b5-1)
25 Jul 2024
Mills Kenneth T. Director
Sold on a plan
$214.50K 15,369 at 13.96
3.6%
Planned (10b5-1)
24 Jul 2024
Mills Kenneth T. Director
Sold on a plan
$168.43K 12,221 at 13.78
2.9%
Planned (10b5-1)
17 Jul 2024
Mills Kenneth T. Director
Sold on a plan
$30.44K 2,210 at 13.77
0.5%
Planned (10b5-1)
16 Jul 2024
Mills Kenneth T. Director
Sold on a plan
$2.75K 200 at 13.76
0.0%
Planned (10b5-1)
1 Jul 2024
Sold on a plan
$112.69K 10,000 at 11.27
47.0%
Planned (10b5-1)
14 May 2024
Mills Kenneth T. President and CEO
Sold on a plan
$237.22K 15,000 at 15.81
3.5%
Planned (10b5-1)
15 Apr 2024
Mills Kenneth T. President and CEO
Sold on a plan
$272.87K 15,000 at 18.19
3.5%
Planned (10b5-1)
14 Mar 2024
Mills Kenneth T. President and CEO
Sold on a plan
$327.94K 15,000 at 21.86
3.5%
Planned (10b5-1)
5 Mar 2024
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$365.22K 12,878 at 28.36
10.7%
Planned (10b5-1)
14 Feb 2024
Mills Kenneth T. President and CEO
Sold on a plan 2×
$251.35K 15,000 at 16.76
3.5%
Planned (10b5-1)
16 Jan 2024
Mills Kenneth T. President and CEO
Sold on a plan
$682.99K 45,000 at 15.18
9.9%
Planned (10b5-1)
3 Jan 2024
PAKOLA STEVE Chief Medical Officer
Sold on a plan
$299.79K 17,237 at 17.39
13.9%
Planned (10b5-1)
19 Dec 2023
Mills Kenneth T. President and CEO
Sold on a plan
$885.83K 45,000 at 19.69
11.2%
Planned (10b5-1)
Showing 1–26 of 26.